Free Newsletter
Examining your relationship with CROs
Today we welcome another regular contributor to our Industry Voices column. Stephanie Wells is the Corporate Senior Vice President, Marketing and Chief Marketing Officer at Charles River Laboratories, a U.S.-based CRO with more than 9,000 employees worldwide. Wells has over twenty-five years of healthcare business experience, and has previously worked at Prior Ortho-Clinical Diagnostics (a Johnson & Johnson company) and Bayer Diagnostics.
Wells' executive position at a leading CRO has given her insight into how biotech and pharmaceutical companies can maximize their relationships with CROs. This changing healthcare landscape, she says, is the driving force behind a collaborative evolution within the industry, transforming traditional pharma-CRO relationships. To get Well's advice, scroll down or click here to read her article on getting the most from your CRO. - Maureen
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FiercePharma email newsletter for FREE!
Be the first to comment